What is Aclaris Therapeutics's cash ratio?

Aclaris Therapeutics (ACRS) reported cash ratio of 1× in Q1 2026.

How has Aclaris Therapeutics's cash ratio changed year-over-year?

Aclaris Therapeutics's cash ratio decreased by 25.8% year-over-year, from 1.4× to 1×.

What is the long-term trend for Aclaris Therapeutics's cash ratio?

Over 5 years (2020 to 2025), Aclaris Therapeutics's cash ratio has grown at a -14.0% compound annual growth rate (CAGR), from 1.5× to 0.7×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Aclaris Therapeutics ACRS Cash ratio

Cash ratio at other companies

IncyteINCY

2.3×+1.2×

Corvus PharmaceuticalsCRVS

3.3×+2.8×

Upstream Bio, Inc.UPB

7.1×-0.4×

Avalo TherapeuticsAVTX

2.2×-20.1×

Shattuck Labs, Inc.STTK

21.3×+13.0×

Apogee Therapeutics, Inc.APGE

13.7×+10.5×

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

cash and equivalents/total current liabilities=1×

Based on the most recent quarter.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's cash ratio?: Aclaris Therapeutics (ACRS) reported cash ratio of 1× in Q1 2026.
How has Aclaris Therapeutics's cash ratio changed year-over-year?: Aclaris Therapeutics's cash ratio decreased by 25.8% year-over-year, from 1.4× to 1×.
What is the long-term trend for Aclaris Therapeutics's cash ratio?: Over 5 years (2020 to 2025), Aclaris Therapeutics's cash ratio has grown at a -14.0% compound annual growth rate (CAGR), from 1.5× to 0.7×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.